A real-world prospective cohort study of immunogenicity and reactogenicity of ChAdOx1-S[recombinant] among patients with immune-mediated dermatological diseases.

Kumutnart Chanprapaph,Chutima Seree-Aphinan,Ploysyne Rattanakaemakorn,Cherrin Pomsoong,Yanisa Ratanapokasatit,Chavachol Setthaudom,Arunee Thitithanyanont, Aphinyaphiwat Suriyo,Thanitta Suangtamai,P Suchonwanit

The British journal of dermatology（2023）

引用 3|浏览4

暂无评分

摘要

Among participants with IMDDs, ChAdOx1-S[recombinant] showed good immunogenicity among patients with psoriasis, but demonstrated lower levels of immunogenicity for patients with AIBD. Some patients, especially patients with AIBD, should be closely monitored as they may require treatment escalation within 1 month postvaccination.

查看译文

关键词

dermatological diseases,immunogenicity,real-world,immune-mediated

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要